5Viedt C, Dechend R, Fei J, et al. MCP-1 Induces Inflammatory Activation of Human Tubular E pithehal Ceils: Involvement of the Transcription Factors, Nuclear Factor-KB and Activating Protein-1 [ J ]. J Am Soc Nephro1,2012,13 (6) : 1'534 - 1547.
6Bourlon PM Faure-Dussert A, Billaudel B. The de novo synthesis of nu- merous proteins is decreased,during vitamin D3 deficiency and is gradu- ally restored by 1,25-dihydroxyvitamin D3 repletion in the islets of langerhans of rats [ J ]. J Endocrino1,2013,162 ( 1 ) : 101 - 109.
7Fuad N. Ziyadeh,Gunter Wolf.Pathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy. Current Diabetes Reviews . 2008
8Kirk N. Campbell,Leopoldo Raij,Peter Mundel.Role of Angiotensin II in the Development of Nephropathy and Podocytopathy of Diabetes. Current Diabetes Reviews . 2011
9Leiter LA,Carr MC,Stewart M,et al.Efficacy and safety of the onceweekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment:a randomized phaseⅢstudy. Diabetes Care . 2014
10M.Ligueros‐Saylan,J. E.Foley,A.Schweizer,A.Couturier,W.Kothny.??An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials(J)Diabetes, Obesity and Metabolism . 2010 (6)
